Charles River Laboratories has unloaded QS Pharma, a Philadelphia-area CDMO, months after picking it up as part of its $585 million buyout of WIL Research.

In a warning letter, the FDA shows its dissatisfaction with manufacturing at an Indian API plant in Bangalore for falling short of standards of cleanliness.

The FDA has banned products from an Australian company's plant in Guangzhou, China, and cited it with “significant violations” of cGMP regulations saying…

The FDA has again slammed a Japanese drug company in a warning letter, this time for not doing enough to prevent contamination during aseptic filling.

Sun Pharma says it could be a few more quarters before it resolves FDA concerns over its key plant in Halol, a situation that continues to be a drag on its…

India’s Aurobindo has acquired four biosimilar products from a Swiss company and says it is building a manufacturing plant to support the production of those…

Eli Lilly is rethinking plans to add a manufacturing line to a plant in Ireland following President Trump’s call on drugmakers to invest in the U.S.

In a meeting with a host of Big Pharma execs last week, President Trump urged them to build plants and manufacture drugs in the U.S. Now a new U.S. plant has…

It is a reversal of fortunes for a Pfizer plant in Australia. The U.S. drugmaker has decided to close the facility and lay off nearly 90 workers after…

Manufacturing